Low reactive level laser therapy for mesenchymal stromal cells therapies

51Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Low reactive level laser therapy (LLLT) is mainly focused on the activation of intracellular or extracellular chromophore and the initiation of cellular signaling by using low power lasers. Over the past forty years, it was realized that the laser therapy had the potential to improve wound healing and reduce pain and inflammation. In recent years, the term LLLT has become widely recognized in the field of regenerative medicine. In this review, we will describe the mechanisms of action of LLLT at a cellular level and introduce the application to mesenchymal stem cells and mesenchymal stromal cells (MSCs) therapies. Finally, our recent research results that LLLT enhanced the MSCs differentiation to osteoblast will also be described.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kushibiki, T., Hirasawa, T., Okawa, S., & Ishihara, M. (2015). Low reactive level laser therapy for mesenchymal stromal cells therapies. Stem Cells International. Hindawi Publishing Corporation. https://doi.org/10.1155/2015/974864

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2506121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

66%

Researcher 12

23%

Professor / Associate Prof. 4

8%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

43%

Biochemistry, Genetics and Molecular Bi... 15

33%

Engineering 7

15%

Agricultural and Biological Sciences 4

9%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 11

Save time finding and organizing research with Mendeley

Sign up for free
0